Quest Diagnostics Incorporated (DGX)
NYSE: DGX · IEX Real-Time Price · USD
136.64
-0.45 (-0.33%)
At close: Jul 2, 2024, 4:00 PM
137.62
+0.98 (0.72%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Quest Diagnostics Market Cap
Quest Diagnostics has a market cap or net worth of $15.18 billion as of July 2, 2024. Its market cap has decreased by -4.22% in one year.
Market Cap
15.18B
Enterprise Value
20.06B
1-Year Change
-4.22%
Ranking
Category
Stock Price
$136.64
Market Cap Chart
Since December 1, 1998, Quest Diagnostics's market cap has increased from $531.80M to $15.18B, an increase of 2,754.38%. That is a compound annual growth rate of 13.99%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 15.23B | -1.76% |
Dec 29, 2023 | 15.50B | -12.99% |
Dec 30, 2022 | 17.82B | -16.05% |
Dec 31, 2021 | 21.22B | 32.15% |
Dec 31, 2020 | 16.06B | 11.65% |
Dec 31, 2019 | 14.38B | 26.95% |
Dec 31, 2018 | 11.33B | -15.59% |
Dec 29, 2017 | 13.42B | 5.36% |
Dec 30, 2016 | 12.74B | 24.94% |
Dec 31, 2015 | 10.20B | 5.21% |
Dec 31, 2014 | 9.69B | 24.48% |
Dec 31, 2013 | 7.79B | -15.94% |
Dec 31, 2012 | 9.26B | 1.13% |
Dec 30, 2011 | 9.16B | -0.41% |
Dec 31, 2010 | 9.20B | -17.62% |
Dec 31, 2009 | 11.16B | 9.95% |
Dec 31, 2008 | 10.15B | -0.86% |
Dec 31, 2007 | 10.24B | -0.93% |
Dec 29, 2006 | 10.34B | -0.63% |
Dec 30, 2005 | 10.40B | 7.59% |
Dec 31, 2004 | 9.67B | 27.23% |
Dec 31, 2003 | 7.60B | 36.58% |
Dec 31, 2002 | 5.56B | -18.81% |
Dec 31, 2001 | 6.85B | 4.46% |
Dec 29, 2000 | 6.56B | 396.99% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Baxter International | 17.05B |
Illumina | 16.63B |
Genmab | 16.37B |
BioMarin Pharmaceutical | 15.63B |
BeiGene | 15.43B |
Sarepta Therapeutics | 14.93B |
Insulet | 14.13B |
United Therapeutics | 14.13B |